WO2025220042 - PHARMACEUTICAL COMPOSITIONS COMPRISING ASUNDEXIAN AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/220042
Publication Date
23.10.2025
International Application No.
PCT/IN2025/050615
International Filing Date
18.04.2025
Title **
[English]
PHARMACEUTICAL COMPOSITIONS COMPRISING ASUNDEXIAN AND USE THEREOF
[French]
COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE L'ASUNDEXIAN ET LEUR UTILISATION
Applicants **
DR. REDDY'S LABORATORIES LIMITED
Inventors
JHA, Romesh
ARORA, Sachin
HANDA, Ajay Kumar
BHATTACHARYA, Saswati
KADAM, Sainath Digambar
Priority Data
202441031172
18.04.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2980 | |
| EPO | Filing, Examination, Granting | 25661 | |
| Japan | Filing, Examination, Granting | 2985 | |
| South Korea | Filing, Examination, Granting | 3931 | |
| USA | Filing, Examination, Granting | 10340 |
Total:
45,897
Contact Us
Abstract[English]
The present invention is directed to liquid pharmaceutical compositions comprising Asundexian, methods for their preparation, and methods of their use. The present invention also relates to stable liquid pharmaceutical compositions comprising Asundexian and one or more pharmaceutically acceptable excipient(s) suitable for oral administration.[French]
La présente invention concerne des compositions pharmaceutiques liquides comprenant de l'asundexian, des procédés pour leur préparation, et des procédés d'utilisation de celles-ci. La présente invention concerne également des compositions pharmaceutiques liquides stables comprenant de l'asundexian et un ou plusieurs excipients pharmaceutiquement acceptables appropriés pour une administration orale.